Step forward in gene therapy to treat cause of sudden cardiac arrest in athletes Dr. Nandita Mohan23 March 2023 9:00 AM ISTPeople with arrhythmogenic cardiomyopathy are born with normal hearts but begin to develop an irregular heartbeat in their 20s or 30s. These...
IIT Kanpur licenses gene therapy to Reliance Life Sciences MD Bureau11 March 2023 10:00 AM ISTThe gene therapy technology from IIT Kanpur will be further developed as an Indigenous Product by Reliance Life Sciences, said an official release...
Novel gene therapy shows promise for treating multiple eye diseases Dr. Kamal Kant Kohli20 Feb 2023 8:00 PM ISTResearchers from Trinity College Dublin have discovered that a potential new gene therapeutic approach may also be effective in treating patients...
EMA seeks to issue guidance on liver damage from Novartis gene therapy Zolgensma Ruchika Sharma15 Jan 2023 12:15 PM ISTThe drug won conditional EU approval during early 2020 and it costs more than $2 million per patient
Medical Bulletin 23/December/2022 Isra Zaman23 Dec 2022 2:30 PM ISTHere are the top medical news for the day:Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancerThe KRAS...
Breakthrough for Artemis-SCID patients in the form of Infant gene therapy Isra Zaman23 Dec 2022 9:15 AM ISTGene correction has been used before in patients with other genetic forms of SCID, but its use in Artemis-SCID is significant because these patients...
FDA Approves Gene Therapy for Treating High-Risk, Non-Muscle-Invasive Bladder Cancer Dr. Kamal Kant Kohli20 Dec 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved Adstiladrin (nadofaragene firadenovec-vncg) for treating high-risk, Bacillus Calmette-Guérin...
Topical gene therapy promising for complete wound healing in dystrophic epidermolysis bullosa patients: NEJM Medha Baranwal15 Dec 2022 8:00 PM ISTUSA: Dystrophic epidermolysis bullosa is a genetic skin disorder that causes the skin to be fragile and blister easily. Mutations in COL7A1 that...
World's most expensive drug: USFDA nod to HEMGENIX worth USD 3.5 million a dose Roshni Dhar25 Nov 2022 5:41 PM ISTGlobal biotechnology leader CSL has announced that the U.S. Food and Drug Administration (USFDA) has approved HEMGENIX (etranacogene...
Health Bulletin 25/November/2022 Roshni Dhar25 Nov 2022 4:51 PM ISTHere are the top health news for the day:Thirteen measles deaths reported in Mumbai An eight-year-old boy from Govandi died on Thursday due to...
First gene therapy for hemophilia B treatment receives FDA approval Dr. Kamal Kant Kohli23 Nov 2022 8:00 PM ISTUSA: Hemgenix, an adeno-associated virus vector-based gene therapy, has received approval from the U.S. Food and Drug Administration (FDA) for the...
Gene therapy for rare blinding disease of children developed by NIH researchers Dr. Kamal Kant Kohli13 Sept 2022 7:30 PM ISTResearchers from the National Eye Institute (NEI) have developed a gene therapy for rare blinding disease of children. The therapy rescues cilia...
